Log in
CNSX:BIO

Bio-Rad Laboratories Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$0.06
MA: $0.08
$0.12
52-Week Range N/A
Volume265,600 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Biome Grow Inc., through its subsidiaries, cultivates, produces, and distributes cannabis at Antigonish, Nova Scotia. The company is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone416-875-8395
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable
30 days | 90 days | 365 days | Advanced Chart

Receive BIO News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bio-Rad Laboratories (CNSX:BIO) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Bio-Rad Laboratories?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bio-Rad Laboratories in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Bio-Rad Laboratories
.

What stocks does MarketBeat like better than Bio-Rad Laboratories?

Wall Street analysts have given Bio-Rad Laboratories a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bio-Rad Laboratories wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for BIO?

1 Wall Street analysts have issued 12 month price objectives for Bio-Rad Laboratories' stock. Their forecasts range from $0.65 to $0.65. On average, they expect Bio-Rad Laboratories' share price to reach $0.65 in the next twelve months.
View analysts' price targets for Bio-Rad Laboratories
.

Who are some of Bio-Rad Laboratories' key competitors?

What other stocks do shareholders of Bio-Rad Laboratories own?

Who are Bio-Rad Laboratories' key executives?

Bio-Rad Laboratories' management team includes the following people:
  • Mr. Khurram Malik, CEO, Pres & Director
  • Mr. Abbey Abdiye, Chief Financial Officer
  • Mr. Frank MacMaster, Pres of Highland Grow Inc.
  • David Callahan, Pres of The Back Home Medical Cannabis Corp.
  • Scott Cuthbertson, VP of Investor Relations

What is Bio-Rad Laboratories' stock symbol?

Bio-Rad Laboratories trades on the CNSX under the ticker symbol "BIO."

How do I buy shares of Bio-Rad Laboratories?

Shares of BIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bio-Rad Laboratories' official website?

The official website for Bio-Rad Laboratories is www.biomegrow.com.

How can I contact Bio-Rad Laboratories?

The company can be reached via phone at 416-875-8395.

This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.